Innovation Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2013 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $3K, a 98.3% decline year-over-year.
  • Innovation Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $32K, a 95.6% decline year-over-year.
  • Innovation Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $207K, a 64.5% decline from 2022.
  • Innovation Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $583K, a 219% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $183K, a 1308% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $32K $3K -$175K -98.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $207K $4K -$181K -97.8% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 $388K $4K -$202K -98.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $590K $21K -$131K -86.2% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-15
Q3 2022 $721K $178K +$138K +345% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $583K $185K +$88K +90.7% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $495K $206K +$165K +402% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $330K $152K +$121K +390% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-15
Q3 2021 $209K $40K +$26K +186% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $183K $97K Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 $41K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $31K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $14K -$286K -95.3% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q3 2019 $300K -$300K -50% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
Q3 2018 $600K -$300K -33.3% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q3 2017 $900K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q1 2017 $336K +$318K +1767% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $347K -$85K -19.7% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-09
Q1 2016 $18K -$5K -21.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $432K +$125K +40.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q1 2015 $23K -$214K -90.3% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $307K +$78K +34.1% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-09
Q1 2014 $237K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $229K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $26K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.